Search for content, post, videos

Category

MedTech Business

magnus-groth-sca
0 COMMENT
96 Views
SCA becomes two listed companies

At the Annual General Meeting of SCA last week, the company’s shareholders voted in favor of the Board of Director’s proposal to split the Group into two listed companies. Essity One of these will continue to operate as SCA, a forest products company that will include the forest products operations…

bonesupport
0 COMMENT
79 Views
Bonesupport extends US distribution agreement

BONESUPPORT has extended the term of its U.S. distribution agreement with Zimmer Biomet, where Zimmer will continue to have exclusive rights for BONESUPPORT’s cerament bone void filler product line for Orthopedics, Trauma and Foot and Ankle indications in the United States. “We are extremely pleased to extend our distribution agreement…

dignitana-cooling-cap
0 COMMENT
98 Views
Nine new installations in US for DigniCap

Dignitana announces that the DigniCap scalp cooling system, which was cleared in December 2015 by the FDA to reduce the likelihood of chemotherapy-induced hair loss in women with breast cancer, will soon be available in nine additional medical centers across the United States including the four locations of University of…

Lena Söderström Senzime
0 COMMENT
39 Views
Senzime signs distribution agreement

Senzime has entered distribution agreements for the commercialization of TetraGraph with Wardray Premise, who will be the exclusive distributor in the UK and Ireland and LSR Healthcare who will be the exclusive distributor in Australia and New Zealand. Compensation to distributors will be paid on a “per-unit sold” basis, and…

agreement
0 COMMENT
33 Views
Enzymatica enters partnership agreement

Enzymatica enters into partnership agreement with STADA Arzneimittel which grants STADA exclusive rights to sell, market and distribute Enzymatica’s common cold product ColdZyme in Germany. Stada is a global pharmaceutical company, headquartered in Germany, with a strong presence in Europe and leading positions in the cough and cold category in…

radiation-therapy
0 COMMENT
27 Views
Elekta enters partnership with ESTRO Cancer Foundation

Elekta recently entered into a partnership with the ESTRO [European Society for Radiotherapy & Oncology] Cancer Foundation (ECF) to contribute – hand in hand with various other partners in academia and industry – to the foundation’s mission to ensure that “every patient in Europe will have access to state-of-the-art radiation…

bactiguard
0 COMMENT
55 Views
Bactiguard and Smartwise in license agreement

Bactiguard and Smartwise Sweden have entered into a joint development project for advanced, Bactiguard-coated vascular injection catheters and at the same time, a license agreement has been signed. Under the agreement, Smartwise will pay USD 2.5 million, for the exclusive and global right to the Bactiguard technology for this application, payable…

elekta-venezia
0 COMMENT
17 Views
Elekta receives FDA clearance

Elekta announces that its Venezia applicator for gynecological brachytherapy has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the treatment of advanced-stage cervical cancer. Venezia received CE Mark approval in November 2016. “There is overwhelming clinical evidence that modern image-guided brachytherapy is an effective treatment modality…

ossdsign
0 COMMENT
38 Views
OssDsign announces new agreement

​OssDsign has signed an agreement with Matador Medical Inc. to act as its master distributor in the US market. OssDsign recently announced FDA 510(k) clearance of OSSDSIGN Cranial PSI, a patient-specific medical implant intended for reconstruction of cranial defects. Matador Medical was founded and is led by Paul Byerley, who…

0 COMMENT
41 Views
DermoScan and SciBase sign agreement

SciBase has signed an agreement with the German medical device company DermoScan to link Nevisense with its EIS measurement for early detection of malignant melanoma, with DermoScan’s digital dermoscopy system DermoGenius Ultra. DermoScan is one of Europe’s foremost manufacturers of digital dermoscopy systems. The agreement means that EIS measurements from…

ossdsign
0 COMMENT
71 Views
OssDsign announces FDA clearance

OssDsign has received 510(k) clearance by the US FDA for marketing of OSSDSIGN Cranial PSI in the USA. “Receiving FDA clearance for our flagship product OSSDSIGN Cranial is extremely positive news. This means we can continue working according to our existing plan of launching OSSDSIGN Cranial on the US market…

bindex
0 COMMENT
21 Views
Bone Index receives FDA clearance

Bone Index has received 510(k) clearance from the Food and Drug Administration (FDA) for the second generation Bindex point-of-care device model to help in osteoporosis diagnosis. Bindex measures the cortical bone thickness of the tibia and the algorithm calculates the Density Index, a parameter which estimates bone mineral density at…

ossdsign
0 COMMENT
33 Views
OssDsign announces new European partnership for commercialization

Karolinska Development announces that portfolio company OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands. OssDsign’s lead products – OSSDSIGN Cranial and OSSDSIGN Facial…

magnus-groth-sca
0 COMMENT
98 Views
SCA to acquire BSN Medical

SCA has entered into an agreement to acquire BSN medical, a medical solutions company, from the private equity group EQT. BSN medical develops, manufactures, markets and sells products within wound care, compression therapy and orthopedics. The purchase price amounts to EUR 2,740m on a debt- and cash-free basis. The completion…

nevisense_doc-pat_arm1
0 COMMENT
75 Views
First delivery of Nevisense View for SciBase

SciBase’s new instrument Nevisense View which combines patented impedance measurement (EIS) for early detection of malignant melanoma with visual information from digital dermoscopy,  has left SciBase for delivery to Belgium. The new instrument Nevisense View integrates images from digital dermoscopy with Nevisense’s EIS-technology.  The result is that all information from…